| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |